NWAM LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Buy |
912
+5
| +0.6% | +$1.7K | 0.03% | 425 |
|
|
2025
Q1 | $245K | Buy |
907
+1
| +0.1% | +$270 | 0.02% | 448 |
|
|
2024
Q4 | $213K | Buy |
906
+50
| +6% | +$11.8K | 0.01% | 559 |
|
|
2024
Q3 | $235K | Buy |
856
+4
| +0.5% | +$1.1K | 0.01% | 552 |
|
|
2024
Q2 | $207K | Buy |
+852
| New | +$207K | 0.06% | 142 |
|
|
2023
Q1 | – | Sell |
-850
| Closed | -$202K | – | 481 |
|
|
2022
Q4 | $202K | Buy |
+850
| New | +$202K | 0.02% | 493 |
|